These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effect of ebrotidine on gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide. Slomiany BL; Piotrowski J; Slomiany A J Physiol Pharmacol; 1999 Sep; 50(3):391-404. PubMed ID: 10574469 [TBL] [Abstract][Full Text] [Related]
24. Role of surfactant protein D (SP-D) in innate immunity in the gastric mucosa: evidence of interaction with Helicobacter pylori lipopolysaccharide. Moran AP; Khamri W; Walker MM; Thursz MR J Endotoxin Res; 2005; 11(6):357-62. PubMed ID: 16303091 [TBL] [Abstract][Full Text] [Related]
25. H. pylori decreases gastric mucin synthesis via inhibition of galactosyltransferase. Tanaka S; Mizuno M; Maga T; Yoshinaga F; Tomoda J; Nasu J; Okada H; Yokota K; Oguma K; Shiratori Y; Tsuji T Hepatogastroenterology; 2003; 50(53):1739-42. PubMed ID: 14571831 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of gastric mucosal mucin receptor by H. pylori lipopolysaccharide: effect of ebrotidine. Slomiany BL; Piotrowski J; Murty VL; Slomiany A Gen Pharmacol; 1995 Nov; 26(7):1553-8. PubMed ID: 8690245 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide: effect of sulglycotide. Piotrowski J; Majka J; Murty VL; Czajkowski A; Slomiany A; Slomiany BL Gen Pharmacol; 1994 Sep; 25(5):969-76. PubMed ID: 7835646 [TBL] [Abstract][Full Text] [Related]
28. Involvement of endothelin-1 in up-regulation of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide. Slomiany BL; Piotrowski J; Slomiany A Biochem Biophys Res Commun; 1999 Apr; 258(1):17-20. PubMed ID: 10222227 [TBL] [Abstract][Full Text] [Related]
29. Effects of pH on Helicobacter pylori binding to human gastric mucins: identification of binding to non-MUC5AC mucins. Lindén S; Mahdavi J; Hedenbro J; Borén T; Carlstedt I Biochem J; 2004 Dec; 384(Pt 2):263-70. PubMed ID: 15260802 [TBL] [Abstract][Full Text] [Related]
30. Mucus and H. pylori. Allen A; Newton J; Oliver L; Jordan N; Strugala V; Pearson JP; Dettmar PW J Physiol Pharmacol; 1997 Sep; 48(3):297-305. PubMed ID: 9376612 [TBL] [Abstract][Full Text] [Related]
31. Apoptosis induction in gastric mucous cells in vitro: lesser potency of Helicobacter pylori than Escherichia coli lipopolysaccharide, but positive interaction with ibuprofen. Durkin E; Moran AP; Hanson PJ J Endotoxin Res; 2006; 12(1):47-56. PubMed ID: 16420743 [TBL] [Abstract][Full Text] [Related]
32. A novel in vitro infection model of Helicobacter pylori using mucin-producing murine gastric surface mucous cells. Takahashi T; Matsumoto T; Nakamura M; Matsui H; Kiyohara H; Sasakawa C; Yamada H Helicobacter; 2004 Aug; 9(4):302-12. PubMed ID: 15270744 [TBL] [Abstract][Full Text] [Related]
33. Effect of methanolic extract of Terminalia arjuna against Helicobacter pylori 26695 lipopolysaccharide-induced gastric ulcer in rats. Devi RS; Kist M; Vani G; Devi CS J Pharm Pharmacol; 2008 Apr; 60(4):505-14. PubMed ID: 18380924 [TBL] [Abstract][Full Text] [Related]
34. Effects of Helicobacter pylori Infection on gastric mucin expression. Kang HM; Kim N; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Lee HS; Jung HC; Song IS J Clin Gastroenterol; 2008 Jan; 42(1):29-35. PubMed ID: 18097286 [TBL] [Abstract][Full Text] [Related]